| abstract |
The present invention relates to a combination of topical inhalation pharmaceutical preparations comprising an anticholinergic component, preferably glycopyrrolate, and a glucocorticosteroid component, as well as tracheal diseases, in particular obstructive ventilation disorders or asthma and chronic obstructive pulmonary disease Are described for use in the symptomatic and prophylactic treatment of basic inflammation. In addition, it includes the presentation of topically applied (inhaled) formulations in inhalation devices such as Novolizer ™ and combinations in application. |